Diane L Reidy-Lagunes

Diane L Reidy-Lagunes

UNVERIFIED PROFILE

Are you Diane L Reidy-Lagunes?   Register this Author

Register author
Diane L Reidy-Lagunes

Diane L Reidy-Lagunes

Publications by authors named "Diane L Reidy-Lagunes"

Are you Diane L Reidy-Lagunes?   Register this Author

14Publications

476Reads

48Profile Views

Complete Responses to Mitotane in Metastatic Adrenocortical Carcinoma-A New Look at an Old Drug.

Oncologist 2017 09 30;22(9):1102-1106. Epub 2017 May 30.

Department of Medicine, Center for Molecular Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599197PMC
September 2017

Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels.

J Clin Oncol 2016 06 28;34(18):2141-7. Epub 2016 Mar 28.

Zsofia K. Stadler, Francesca Battaglin, Sumit Middha, Jaclyn F. Hechtman, Christina Tran, Andrea Cercek, Rona Yaeger, Neil H. Segal, Anna M. Varghese, Diane L. Reidy-Lagunes, Nancy E. Kemeny, Erin E. Salo-Mullen, Asad Ashraf, Martin R. Weiser, Julio Garcia-Aguilar, Mark E. Robson, Kenneth Offit, Maria E. Arcila, Michael F. Berger, Jinru Shia, David B. Solit, and Leonard B. Saltz, Memorial Sloan Kettering Cancer Center, New York, NY; and Francesca Battaglin, Veneto Institute of Oncology, Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.1067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962706PMC
June 2016

New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.

Clin Adv Hematol Oncol 2015 May;13(5 Suppl 5):1-18; quiz 1 p following 18

Stanford University School of Medicine, Stanford, California.

View Article

Download full-text PDF

Source
May 2015

Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer.

J Natl Compr Canc Netw 2014 Apr;12(4):513-9

From the aGastrointestinal Oncology Service, Department of Medicine, bDepartment of Radiation Therapy, and cColorectal Surgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/4/513.full.pdf
Web Search
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612781PMC
http://dx.doi.org/10.6004/jnccn.2014.0056DOI Listing
April 2014

A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma.

J Hepatol 2014 Feb 14;60(2):319-24. Epub 2013 Sep 14.

Department of Internal Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States; Department of Internal Medicine, Weill Medical College at Cornell University, New York, NY, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2013.09.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901953PMC
February 2014

A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors.

Cancer 2012 Oct 21;118(19):4795-800. Epub 2012 Mar 21.

Department of Medicine, Division of Solid Tumors, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27459DOI Listing
October 2012

Systemic therapy for advanced pancreatic neuroendocrine tumors: an update.

J Natl Compr Canc Netw 2012 Jun;10(6):777-83

Division of Solid Tumor Oncology, Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, and Weill College of Medicine, Cornell University, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2012.0077DOI Listing
June 2012